- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €353.5m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.98
7D
-0.6%
1Y
-25.0%
Heidelberg Pharma
Market Cap: €122.1m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally.
HPHA
€2.65
7D
1.5%
1Y
-38.1%
Cantourage Group
Market Cap: €77.8m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€6.06
7D
-7.6%
1Y
-7.3%
Darwin
Market Cap: €72.0m
Operates in the healthcare industry.
7V0
€6.00
7D
0%
1Y
n/a